Researchers seek genetic clues to identify addicts and patients who will benefit from treatment
A study examines the potential of pharmacogenomic testing to help drug-treatment centers select suitable treatment regimens for opiate-addicted patients. The research investigates genetic polymorphisms affecting opioid metabolism, aiming to improve pain management and drug-abuse treatment.